Lymphoplasmacytic lymphoma: Difference between revisions
From IDWiki
m (Text replacement - "Clinical Presentation" to "Clinical Manifestations") |
No edit summary |
||
Line 1: | Line 1: | ||
== Definition == |
== Definition == |
||
* Low-grade B-cell neoplasm frequently causing an IgM gammopathy (at which point it is called |
* Low-grade B-cell neoplasm frequently causing an IgM gammopathy (at which point it is called [[Waldenström macroglobulinemia]]) |
||
== Investigations == |
== Investigations == |
||
Line 10: | Line 10: | ||
* Hyperviscosity, including neurological symptoms |
* Hyperviscosity, including neurological symptoms |
||
* Peripheral neuropathy |
* [[Peripheral neuropathy]] |
||
* Lymphadenopathy, organomegaly, cytopenia |
* Lymphadenopathy, organomegaly, cytopenia |
||
* Constitutional symptoms |
* Constitutional symptoms |
||
Line 19: | Line 19: | ||
* Treatment only indicated if symptoms progressing |
* Treatment only indicated if symptoms progressing |
||
* From most to least effective (and most to least side effects): |
* From most to least effective (and most to least side effects): |
||
** RCP: rituximab, cyclophosphamide, prednisone (or dexamethasone for DRC) |
** [[RCP]]: [[rituximab]], [[cyclophosphamide]], [[prednisone]] (or [[dexamethasone]] for [[DRC]]) |
||
** BR: bendamustine/rituximab |
** [[BR]]: [[bendamustine]]/[[rituximab]] |
||
** Chlorambucil/Obinutuzumab |
** [[Chlorambucil]]/[[Obinutuzumab]] |
||
** Ibrutinib |
** [[Ibrutinib]] |
||
* Before chemotherapy, screen for hepatitis B +/- TB/ |
* Before chemotherapy, screen for [[hepatitis B]] +/- [[TB]]/[[Strongyloides]] |
||
[[Category:Hematology]] |
[[Category:Hematology]] |
Latest revision as of 18:03, 26 July 2023
Definition
- Low-grade B-cell neoplasm frequently causing an IgM gammopathy (at which point it is called Waldenström macroglobulinemia)
Investigations
- SPEP and immunofixation showing IgM-kappa M-protein
Clinical Manifestations
- Hyperviscosity, including neurological symptoms
- Peripheral neuropathy
- Lymphadenopathy, organomegaly, cytopenia
- Constitutional symptoms
Management
- Depends on underlying health and age
- Treatment only indicated if symptoms progressing
- From most to least effective (and most to least side effects):
- Before chemotherapy, screen for hepatitis B +/- TB/Strongyloides